Results of a Phase 1B Multicenter Study Evaluating the Safety and Potential Activity of Two Escalating Doses of hMaxi-K Gene Transfer by Direct Injection into the Bladder Wall in Female Participants with Idiopathic (Non-neurogenic) Overactive Bladder Syndrome and Detrusor Overactivity: Double Blind, Imbalanced Placebo Controlled Design Within 2 Sequential Active Treatment Groups

Chai T1, Rovner E2, Jacobs S3, Christ G4, Andersson K5, Efros M6, Nitti V7, Melman A8

Research Type


Abstract Category

Overactive Bladder

Abstract 15
Lower Urinary Tract and Therapeutics
Scientific Podium Short Oral Session 2
Wednesday 13th September 2017
10:00 - 10:07
Cavaniglia B
Overactive Bladder Urgency Urinary Incontinence Nocturia Urgency/Frequency Prospective Study
1. Yale University, 2. University of South Carolina, 3. Ion Channel Innovations, LLC, 4. Universty of Virginia, 5. WFIRM, Wake Forest University, 6. Accumed Research Associates, 7. NYU Medical Center, 8. Ion Channel Innovations, LLC/Albert Einstein College of Medicine

Eric Rovner